The Yawkey building entrance is now closed.

As of April 29, BMC’s Yawkey building doors are closed as an entrance. All patients and visitors on our main campus must enter the hospital via the Shapiro, Menino, or Moakley buildings, where they will be greeted by team members at a new centralized check-in desk. Learn more.

About

Adam Lerner, MD, is a medical oncologist at Boston Medical Center (BMC) and Professor of Hematology and Medical Oncology and Pathology and Laboratory Medicine at Boston University Chobanian & Avedisian School of Medicine. Dr. Lerner is an expert in chronic lymphocytic leukemia, lymphoid malignancies, sarcoma, breast cancer, and cAMP signaling, a process that controls a range of cellular functions including growth, differentiation, and more. At BMC, he provides care for patients with blood cancers, skin cancers, and sarcomas (bone and soft tissue cancers). Dr. Lerner is a member of the BU-BMC Cancer Center, the BU Evans Center for Interdisciplinary Biomedical Research, and the BU Genome Science Institute. At Boston University Chobanian & Avedisian School of Medicine, he mentors students in the Graduate Medical Sciences program.

  • Departments

  • Specialties

    Chronic lymphocytic leukemia, lymphoid malignancies, sarcoma, breast cancer, and cAMP signaling

  • Administrative Title

    Professor of Hematology and Medical Oncology, Pathology and Laboratory Medicine, Boston University Chobanian and Avedisian School of Medicine. Member, Boston University Evans Center for Interdisciplinary Biomedical Research. Member, Genome Science Institute, Boston University.

  • Residency

    Internal Medicine and Anatomic and Clinical Pathology, Boston University Medical Center
  • Fellowship

    Medical Oncology, Dana Farber Cancer Institute
  • Board Certifications

    Internal Medicine and Medical Oncology, American Board of Internal Medicine

Affiliations

Affiliations